After Conference Cancellations, Some Scientists Find a Way

As scores of academic meetings get upended due to COVID-19, researchers are turning to virtual replacements.

Written byDiana Kwon
| 5 min read
coronavirus covid-19 sars-cov-2 scientific conferences virtual meeting research cancellations

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM, SCHARVIK

Within a matter of weeks, COVID-19 changed the world. Borders are sealed, schools and businesses shuttered, and millions of people are hunkered down in their homes. The spread of the coronavirus, SARS-CoV-2, has forced cancellations across almost every sector of society, including sports competitions, weddings, trade fairs, and music and film festivals. Academia has not been spared. In the face of the pandemic, scientific conferences have quickly morphed from a place to share ideas and make new connections to potential hotspots of infection.

In the life sciences alone, dozens of meetings have been canceled, postponed, or moved online. Some researchers have planned online replacements. Many are worried about broader disruptions to academic life.

For many scientists, these conferences are a chance to share research, learn new skills, and meet future supervisors, students, and collaborators. Aadel Chaudhuri, a professor of radiation oncology at the Washington University School ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies